The frontotemporal disorder treatment market was valued at $414.1 million in 2025 and is projected to reach $785.4 million by 2035, growing at a CAGR of 6.8% during the forecast period (2026–2035). The increasing prevalence of neurodegenerative disorders, coupled with rising awareness and early diagnosis initiatives, is significantly driving demand for effective treatment solutions. Frontotemporal disorders (FTD), characterized by progressive neuronal degeneration in the frontal and temporal lobes, require both pharmacological and supportive care approaches to manage behavioural, cognitive, and language impairments.

Food packaging market is projected to grow from $427.4 billion in 2025 to $744.1 billion by 2035, expanding at a CAGR of 5.8% during the forecast period. The market growth is primarily driven by increasing demand for packaged and convenience foods, rapid expansion of e-commerce grocery distribution, and rising focus on food safety, shelf-life extension, and sustainable packaging solutions. A key macro driver influencing the market is the continuous growth of the global food and beverage industry. According to the Food and Agriculture Organization (FAO), global food consumption continues to rise steadily due to population growth, urbanisation, and changing consumer lifestyles. In addition, the United Nations projects the global population to exceed 8.5 billion by 2030, significantly increasing demand for packaged food products and efficient food distribution systems.

Farm animal health market was valued at $25.4 billion in 2025 and is projected to reach $41.5 billion by 2035, growing at a CAGR of 5.0% during the forecast period (2026-2035). The rising focus on livestock disease prevention, food safety standards, and productivity optimization is strengthening demand for advanced animal healthcare solutions across the global agricultural sector. Governments and regulatory authorities are increasingly emphasizing disease surveillance, vaccination programs, and antimicrobial stewardship to ensure sustainable livestock production and food security. Farm animal health products such as vaccines, pharmaceuticals, feed additives, diagnostics, and veterinary medical devices play a critical role in maintaining herd health, reducing mortality rates, and improving production efficiency.

Electron guns market is projected to grow from $1.1 billion in 2025 to $1.7 billion by 2035, registering a CAGR of 4.3% during the forecast period (2026–2035). The market expansion is strongly influenced by rising demand from semiconductor manufacturing and advanced imaging technologies. A key macro driver is the rapid growth of the global semiconductor industry. According to the International Telecommunication Union, over 5.4 billion people (67% of the global population) were using the internet in 2023, significantly increasing demand for electronic devices and data infrastructure. This surge directly accelerates semiconductor production, where electron guns are essential in inspection, lithography, and fabrication processes. Additionally, the International Energy Agency reports that global electricity demand grew by over 2% annually in recent years, driven by digitalisation and industrial automation. 

Digital assistant in the healthcare market was valued at $2.5 billion in 2025 and is projected to reach $13.9 billion by 2035, growing at a CAGR of 18.6% during the forecast period (2026-2035). The rising pressure on healthcare systems to reduce administrative burden, improve patient engagement, and enhance operational efficiency is accelerating the adoption of AI-powered digital assistants across hospitals, clinics, and virtual care platforms. Healthcare providers are increasingly integrating voice-enabled assistants, conversational AI, and generative AI technologies into clinical workflows to support appointment scheduling, documentation, medication reminders, and remote patient monitoring. The market is witnessing rapid adoption of cloud-based and multimodal digital assistants as healthcare organizations focus on improving patient outcomes while reducing clinician workload and healthcare delivery costs.

Corrugated board packaging market was valued at $212.1 billion in 2025 and is projected to reach $329.3 billion by 2035, growing at a CAGR of 4.5% during the forecast period (2026–2035). The increasing emphasis on sustainable packaging solutions and circular economy practices is significantly driving demand for corrugated board packaging across global industries. Governments and regulatory bodies are actively promoting the reduction of single-use plastics, encouraging the adoption of recyclable and biodegradable materials. Corrugated packaging, being renewable, recyclable, and cost-efficient, is witnessing strong demand across food, e-commerce, and industrial supply chains.

Biocontrol agent market was valued at $10.1 billion in 2025 and is projected to reach $45.1 billion by 2035, growing at a CAGR of 16.2% during the forecast period (2026-2035). The increasing global emphasis on sustainable agriculture and the reduction of chemical pesticide usage is significantly driving demand for biocontrol agents across the agricultural sector. Governments and regulatory bodies globally are encouraging environmentally friendly crop protection practices to address soil degradation, biodiversity loss, and pesticide residue concerns. Biocontrol agents play a critical role in integrated pest management (IPM) by utilizing naturally derived microorganisms, beneficial insects, and biochemical compounds to control pests while minimizing environmental impact. The market is witnessing rising adoption of microbial and macro-organism biocontrol solutions across both conventional and organic farming systems.

Biguanide market was valued at $5.8 billion in 2025 and is projected to reach $8.1 billion by 2035, growing at a CAGR of 3.5% during the forecast period (2026–2035). The increasing global burden of diabetes, particularly type 2 diabetes, is significantly strengthening demand for biguanide-based therapies. Biguanides, especially metformin, remain the first-line pharmacological treatment due to their proven efficacy, safety profile, and cost-effectiveness. Rising awareness regarding early diagnosis and long-term glycemic control is further driving prescription volumes across both developed and emerging healthcare markets.

Amyotrophic Lateral Sclerosis treatment market was valued at $1.5 billion in 2025 and is projected to reach $3.5 billion by 2035, growing at a CAGR of 8.9% during 2026–2035. The market is experiencing steady expansion due to the rising prevalence of neurodegenerative disorders, increasing adoption of disease-modifying therapies, and growing investment in gene-targeted treatment approaches. Advancements in precision medicine and expanding research activities focused on rare neurological diseases are further supporting the development of innovative ALS therapeutics. Pharmaceutical companies are increasingly prioritizing antisense oligonucleotide therapies, neuroprotective drugs, and targeted biologics to address the significant unmet clinical needs associated with ALS. In addition, supportive regulatory frameworks and orphan-drug incentives are accelerating commercialization activities across major healthcare markets.

Alcohol ingredients market is projected to grow from $3.5 billion in 2025 to $6.4 billion by 2035, expanding at a CAGR of 6.2% during the forecast period. The market growth is primarily driven by increasing global consumption of alcoholic beverages, rising demand for premium and craft alcoholic products, and continuous innovation in fermentation, Flavoring, and beverage formulation technologies. A key macro driver influencing the market is the steady expansion of the global alcoholic beverage industry. According to data from the World Health Organization (WHO) and industry beverage associations, global alcohol consumption continues to increase across emerging economies, while premiumization trends are reshaping consumer preferences in mature markets. Additionally, the growth of ready-to-drink (RTD) alcoholic beverages and flavored alcoholic drinks is significantly increasing the demand for specialized ingredients such as flavors, enzymes, yeast, and stabilizers. From an application standpoint, beer remains the dominant segment due to high-volume production and significant usage of yeast, hops, enzymes, and adjuncts in brewing operations.